Skip to main content
Pediatrics Pediatric Endocrinology and Diabetology

Pediatric Endocrinology and Diabetology

How can you establish trust with children?

Establishing trust is a foundational skill for healthcare providers who work with children, but there’s no formal training on how to do it. Now there’s a framework to help you.

Read more

Editor's Choice

Managing andrological disorders from childhood to transition age

Open Access Andrology Guideline

Recommendations for the evaluation and management of andrological disorders during childhood and adolescence to transition age, including varicoceles, gynecomastia, and macroorchidism.

An unusual course of diabetes

Diabetes Case Study

A woman with a history of neonatal hyperglycemia and a relatively uneventful childhood without treatment, experienced significant hyperglycemia and retinopathy in adulthood, but what was the cause of her diabetes?

Lipid abnormalities in youth

Dyslipidemia in young people increases the risk for early development of atherosclerotic cardiovascular disease. Lifestyle modifications remain the cornerstone of treatment, but a growing number of lipid-lowering therapies are safe and effective.

COVID-19 accelerates childhood type 1 diabetes progression

30-07-2024 COVID-19 News

COVID-19 infection accelerates the development of clinical type 1 diabetes among children who are presymptomatic for the condition.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Case Studies

An unusual course of diabetes

Diabetes Case Study

A woman with a history of neonatal hyperglycemia and a relatively uneventful childhood without treatment, experienced significant hyperglycemia and retinopathy in adulthood, but what was the cause of her diabetes?

Severe cobalamin C deficiency

Open Access Metabolic Disease in Childhood Case Study

Nephrotic syndrome is usually caused by primary renal disorders, but you should consider metabolic diseases in atypical cases. This 7-month-old presented with nephrotic syndrome, malignant hypertension, and hemolytic anemia.

Siblings with familial chylomicronemia syndrome

Open Access Hypertriglyceridemia Case Study

Familial chylomicronemia syndrome is a monogenic form of severe hypertriglyceridemia that increases the risk of pancreatitis. In this case, two brothers had familial chylomicronemia syndrome caused by rare GPIHBP1 deletions.

Current Reviews

Neurological symptoms in adults with Gaucher disease: a systematic review

Open Access Gaucher Disease Review

Gaucher disease (GD), one of the most common lysosomal storage diseases, results from biallelic variants in the GBA1 gene located on chromosome 1 (1q21), leading to a defective glucocerebrosidase protein (GCase). This lysosomal enzyme plays a …

Hematopoietic Stem Cell Transplantation for Storage Disorders: Present Status

Storage disorders are a group of inborn errors of metabolism caused by the defective activity of lysosomal enzymes or transporters. All of these disorders have multisystem involvement with variable degrees of neurological features. Neurological …

Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies

Open Access Alzheimer's Disease Review

Tauopathies are a heterogeneous group of neurologic diseases characterized by pathological axodendritic distribution, ectopic expression, and/or phosphorylation and aggregation of the microtubule-associated protein TAU, encoded by the gene MAPT.

A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment

Gaucher Disease Review article

Gaucher disease (GD) is a rare lysosomal storage disease that is caused by mutations in the GBA gene. It is classified into three main phenotypes according to the patient’s clinical presentation. Of these, chronic neuronopathic GD (GD3) is …

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

News | Articles | Podcasts | Cases (Link opens in a new window)

Join Prof. Martin Savage and expert colleagues for this series of interviews exploring how to successfully implement precision medicine into the management of pediatric endocrine disorders.

Supported by:
  • Merck Healthcare KGaA, Darmstadt, Germany
Developed by: Springer Healthcare IME

Further Reading

Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)

Open Access Gaucher Disease Original Research

Gaucher disease (GD) is a rare lysosomal storage disorder caused by biallelic mutations in the acid β-glucosidase ( GBA1 ) gene, which lead to reduced acid β-glucosidase activity with consequent accumulation of its primary substrate …

Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study

Open Access Niemann-Pick Disease Research

Niemann-Pick disease type C (NP-C) is a rare autosomal recessive neurovisceral lipid storage disease characterized in a majority of cases by progressive neurological deterioration leading to premature death, and (hepato)splenomegaly; its estimated …

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

Open Access Niemann-Pick Disease Research

Acid Sphingomyelinase Deficiency (ASMD; alternatively known as Niemann–Pick Disease Types A, B and A/B, OMID# 257,200 and 607,616) is an ultra-rare multisystem genetic disorder caused by pathogenic variants of the SMPD1 gene. Clinical features …

Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults

Open Access Niemann-Pick Disease Research

Acid sphingomyelinase deficiency (ASMD) is an autosomal recessive lysosomal storage disease resulting from biallelic pathogenic variants in the SMPD1 gene encoding the lysosomal enzyme acid sphingomyelinase (ASM) [ 1 ]. ASMD presents a clinical …